Volume 121, Issue 4, Pages 973-974.e2 (April 2014) The IL-8, VEGF, and CFH Polymorphisms and Bevacizumab in Age-related Macular Degeneration  Asta Hautamäki, MD, Jarno Kivioja, MSc, Sanna Seitsonen, MD, PhD, Eeva-Riitta Savolainen, MD, PhD, M. Johanna Liinamaa, MD, PhD, Arto Luoma, PhD, Irma Järvelä, MD, PhD, Ilkka Immonen, MD, PhD  Ophthalmology  Volume 121, Issue 4, Pages 973-974.e2 (April 2014) DOI: 10.1016/j.ophtha.2013.11.035 Copyright © 2014 American Academy of Ophthalmology Terms and Conditions

Figure 1 Distribution of the ratios of visits at which intra- or subretinal fluid was detected in relation to all visits of each patient during the 2 years follow-up in each polymorphism group and in groups of differing risk allele frequencies. Risk alleles were defined as A in IL-8 rs4073, A in VEGF rs699947, and C in CFH rs1061170. IL = interleukin; NS = nonsignificant. *P = 0.048 (Kruskal Wallis), **P = 0.002, ***P = 0.00012, and ****P = 0.000022 (Mann-Whitney U test) compared with the group with lowest sum of risk alleles. Ophthalmology 2014 121, 973-974.e2DOI: (10.1016/j.ophtha.2013.11.035) Copyright © 2014 American Academy of Ophthalmology Terms and Conditions